Global Cabazitaxel Market Insights, Forecast to 2025

Global Cabazitaxel Market Insights, Forecast to 2025

  • QYResearch
  • January 2019
  • Pharmaceutical
  • 112 pages

Report Description

1
1
Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.
Global cabazitaxel production regions are mainly distributed in USA and Europe. There is no doubt that USA is the largest production region in the world. In the future, we predict that there will be more and more cabazitaxel suppliers as soon as Sanofis Cabazitaxel patent expired. By 2024, global production will be 1427.4 Kg.
Currently, there are four major cabazitaxel API suppliers globally, including Sanofi, Tapi Teva, Fuan Pharmaceutical Group and Fujian Yewpark Biological etc. Sanofi is the global leader in this industry. According to our research, Sanofi had provided 845.8 Kg cabazitaxel API in 2017, which account for 95.32% of global market.
The global Cabazitaxel market is valued at 170 million US$ in 2018 and will reach 250 million US$ by the end of 2025, growing at a CAGR of 5.3% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cabazitaxel market based on company, product type, end user and key regions.

This report studies the global market size of Cabazitaxel in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cabazitaxel in these regions.
This research report categorizes the global Cabazitaxel market by top players/brands, region, type and end user. This report also studies the global Cabazitaxel market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
Tapi Teva
Fuan Pharmaceutical Group
Fujian Yewpark Biological

Market size by Product
Type I
Type II
Market size by End User
Age Below 65
Age Above 65

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Cabazitaxel market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cabazitaxel market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cabazitaxel companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cabazitaxel submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Cabazitaxel are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cabazitaxel market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Have query on this report?

Make an Enquiry
Table of Contents
1 Study Coverage
1.1 Cabazitaxel Product
1.2 Market Segments
1.3 Key Manufacturers Covered
List of Tables and Figures
Figure Cabazitaxel Product Picture
Table Cabazitaxel Market Segments
Table Key Manufacturers Cabazitaxel Covered
Table Global Cabazitaxel Market Size Growth Rate by Product 2019-2025 (Kg) & (Million US$)
Figure Global Cabazitaxel Sales Market Share by Product 2014-2025

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074